ArticlePediatric dermatology
Antibody Serologies and Diagnostic Considerations in Reactive Infectious Mucocutaneous Eruption.
Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antibody Serologies and Diagnostic Considerations in Reactive Infectious Mucocutaneous Eruption.Pediatric dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive infectious mucocutaneous eruption (RIME) is an uncommon, post-infectious mucocutaneous condition often associated with Mycoplasma pneumoniae , but which can be triggered by other pathogens. We retrospectively reviewed eight young adult patients diagnosed with RIME over a 10-year period, all of whom had positive Mycoplasma pneumoniae serology despite negative respiratory pathogen panel PCR results. Findings suggest serology may be more reliable than PCR testing in suspected RIME, as PCR is prone to false negatives due to timing, pathogen load, and sampling challenges. Early serology testing and consideration of empiric treatment targeting Mycoplasma pneumoniae may improve diagnosis and management, though further studies are warranted to guide standardized testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.